🚀 VC round data is live in beta, check it out!
- Public Comps
- ZhongAn
ZhongAn Valuation Multiples
Discover revenue and EBITDA valuation multiples for ZhongAn and similar public comparables like Rasan, Slide Insurance Holdings, Lemonade, Oscar Health and more.
ZhongAn Overview
About ZhongAn
With headquarters in Shanghai, ZhongAn was founded by Ant Financial, Tencent, Ping An Insurance, and other well-known enterprises in 2013. The company is the first internet-based insurance company in China. It provides online underwriting and claim services through the internet without any offline branches. ZhongAn was listed in September 2017 in Hong Kong. Besides the online insurance segment, the company operates technology and banking segments. Its insurance technology segment exports digital operating systems, middle platforms, and industry models to licensed financial players both domestically and overseas. Its banking segment, through Hong Kong-based virtual ZA Bank, is the largest in Hong Kong by total assets.
Founded
2013
HQ

Employees
2.4K
Website
Sectors
Financials (LTM)
EV
$3B
ZhongAn Financials
ZhongAn reported last 12-month revenue of $5B and EBITDA of $231M.
In the same LTM period, ZhongAn generated $231M in EBITDA and $167M in net income.
Revenue (LTM)
ZhongAn P&L
In the most recent fiscal year, ZhongAn reported revenue of $5B and net income of $88M.
ZhongAn expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $5B | XXX | $5B | XXX | XXX | XXX |
| EBITDA | $231M | XXX | — | XXX | XXX | XXX |
| EBITDA Margin | 5% | XXX | — | XXX | XXX | XXX |
| EBIT Margin | 5% | XXX | — | XXX | XXX | XXX |
| Net Profit | $167M | XXX | $88M | XXX | XXX | XXX |
| Net Margin | 3% | XXX | 2% | XXX | XXX | XXX |
| Net Debt | — | — | $804M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
ZhongAn Stock Performance
ZhongAn has current market cap of $3B, and enterprise value of $3B.
Market Cap Evolution
ZhongAn's stock price is $1.86.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3B | $3B | 0.0% | XXX | XXX | XXX | $0.05 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialZhongAn Valuation Multiples
ZhongAn trades at 0.7x EV/Revenue multiple, and 14.6x EV/EBITDA.
EV / Revenue (LTM)
ZhongAn Financial Valuation Multiples
As of March 20, 2026, ZhongAn has market cap of $3B and EV of $3B.
Equity research analysts estimate ZhongAn's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
ZhongAn has a P/E ratio of 18.8x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV/Revenue | 0.7x | XXX | 0.7x | XXX | XXX | XXX |
| EV/EBITDA | 14.6x | XXX | — | XXX | XXX | XXX |
| EV/EBIT | 14.6x | XXX | — | XXX | XXX | XXX |
| P/E | 18.8x | XXX | 35.7x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 21.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified ZhongAn Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


ZhongAn Margins & Growth Rates
ZhongAn's revenue in the last 12 month grew by 9%.
ZhongAn's revenue per employee in the last FY averaged $2.1M.
ZhongAn's rule of 40 is 14% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
ZhongAn's rule of X is 27% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
ZhongAn Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | (1%) | XXX | XXX | XXX |
| EBITDA Margin | 5% | XXX | — | XXX | XXX | XXX |
| EBITDA Growth | (5%) | XXX | — | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 14% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 27% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $2.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 12% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 9% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
ZhongAn Public Comps
See public comps and valuation multiples for other Neoinsurance comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Rasan | XXX | XXX | XXX | XXX | XXX | XXX |
| Slide Insurance Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| Lemonade | XXX | XXX | XXX | XXX | XXX | XXX |
| Oscar Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Exzeo Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
ZhongAn M&A Activity
ZhongAn acquired XXX companies to date.
Last acquisition by ZhongAn was on XXXXXXXX, XXXXX. ZhongAn acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by ZhongAn
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialZhongAn Investment Activity
ZhongAn invested in XXX companies to date.
ZhongAn made its latest investment on XXXXXXXX, XXXXX. ZhongAn invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by ZhongAn
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout ZhongAn
| When was ZhongAn founded? | ZhongAn was founded in 2013. |
| Where is ZhongAn headquartered? | ZhongAn is headquartered in China. |
| How many employees does ZhongAn have? | As of today, ZhongAn has over 2K employees. |
| Who is the CEO of ZhongAn? | ZhongAn's CEO is Xing Jiang. |
| Is ZhongAn publicly listed? | Yes, ZhongAn is a public company listed on HKEX. |
| What is the stock symbol of ZhongAn? | ZhongAn trades under 06060 ticker. |
| When did ZhongAn go public? | ZhongAn went public in 2017. |
| Who are competitors of ZhongAn? | ZhongAn main competitors are Rasan, Slide Insurance Holdings, Lemonade, Oscar Health. |
| What is the current market cap of ZhongAn? | ZhongAn's current market cap is $3B. |
| What is the current revenue of ZhongAn? | ZhongAn's last 12 months revenue is $5B. |
| What is the current revenue growth of ZhongAn? | ZhongAn revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of ZhongAn? | Current revenue multiple of ZhongAn is 0.7x. |
| Is ZhongAn profitable? | Yes, ZhongAn is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of ZhongAn? | ZhongAn's last 12 months EBITDA is $231M. |
| What is ZhongAn's EBITDA margin? | ZhongAn's last 12 months EBITDA margin is 5%. |
| What is the current EV/EBITDA multiple of ZhongAn? | Current EBITDA multiple of ZhongAn is 14.6x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.